In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells

In Vivo

Volumn 19, Issue 2, 2005, Pages 367-374

  Gyemant N ^a   Tanaka, M ^a   Antus, S ^b   Hohmann, J ^a   Csuka, O ^c   Mandoky L ^c   Molnár, Joseph ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Flavonoids; Isoflavonoids; Multidrug resistance; P glycoprotein

Indexed keywords

12 HYDROXYAMORPHIGENIN; 2,7 BIS(CARBOXYETHYL) 6 CARBOXYFLUORESCEIN; 6A,12A DEHYROAMORPHIGENIN; AFRORMOSIN; AMORPHIGENIN; AURANTIIN; CATECHIN; CHRYSIN; DIMETHYL SULFOXIDE; EPIGALLOCATECHIN; EPIRUBICIN; FLAVONOID; FORMONONETIN; GLYCOPROTEIN P; HESPERIDIN; INDOMETACIN; ISOFLAVONOID; KAEMPFEROL; MULTIDRUG RESISTANCE PROTEIN 1; NEOHESPERIDIN; PHLORETIN; PHLORIZIN; RHODAMINE 123; ROBINETIN; ROBININ; ROTENONE; SAKURANETIN; SAKURANETIN 5 GLUCOSIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION;

EID: 16344368469     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Simon M and Schindler M: Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91: 3497-3504, 1994.
2. Cole SPC and Deeley RG: Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioassay 20: 931-940, 1998.
3. Scheffer GL, Wijngaard PL, Flens M J, Izquierdo MA, Slovak M L, Pinedo HM, Meijer CJ, Clevers HC and Scheper RJ: The drug resistance related protein LRP is the human major vault protein. Nat Med 1: 578-582, 1995.
4. Nooter K, Bosman FT, Burger H, van Wingerden KE, Flens, MJ, Scheper RJ, Oostrum R G, Boersma AW, van der Gaast A and Stoter G: Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol 7: 75-81, 1996.
5. Allen JD, Brinkhuris RF, Wijnholds J and Schinkel AH: The mouse Bcrp1, Mxr, Abcp gene: amplification and overexpression in cell lines selected for resistance to topothecan, mitoxanthrone or doxorubicin. Cancer Res 59: 4237-4241, 1999.
6. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: a Global Perspective. 1997.
7. Harborne JB, Mabry TJ and Mabry H: The Flavonoids. Chapman and Hall, (London) 1975.
8. Le Marchand L: Cancer preventive effects of flavonoids - a review. Biomed Pharmacother 56: 296-301, 2002.
9. Kazi A, Smith, DM, Daniel K, Zhong S, Gupta P, Bosley ME and Dou PQ: Potential molecular targets of tea polyphenols in human tumor cells: Significance in cancer prevention. In Vivo 16: 397-404, 2002.
10. Bobrowska-Hägerstrand M, Wróbel A, Rychlik B, Bartosz G, Söderström T, Shirataki Y, Motohasi N, Molnár J, Michalak K and Hägerstrand H: Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones. Blood Cells Mol Dis 27 894-900, 2001.
11. Cornwell MM, Pastan I and Gottesmann MM: Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170, 1987.
12. Gruber A, Peterson C and Reizenstein P: D-Verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Int J Cancer 41: 224-226, 1988.
13. Molnar J, Mucsi I, Nacsa J, Hever A, Gyemant N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H and Varga A: New silicon compounds as resistance modifiers against multidrug resistant cancer cells. Anticancer Res 24: 865-71, 2004.
14. Draper MP, Martell RL and Levy SB: Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br J Cancer 75: 810-815, 1997.
15. Rychlik B, Puaski L, Sokal A, Soszyñski M and Bartosz G: Transport of organic anions by multidrug resistance-associated protein in the erythrocyte. Acta Biochem Pol 47: 763-772, 2000.
16. Motohashi N, Wakabayashi H, Kurihara T, Takada Y, Maruyama S, Sakagami H, Nakashima H, Tani S, Shirataki Y, Kawase M, Wolfard K and Molnar J: Cytotoxic and multidrug resistance reversal activity of a vegetable, 'Anastasia Red', a variety of sweet pepper. Phytother Res 17: 348-352, 2003.
17. Molnar J, Szabo D, Pusztai R, Mucsi I, Berek L, Ocsovszki I, Kawata E and Shoyama Y: Membrane associated antitumor effects of crocine, ginsenoside and cannabinoid derivatives. Anticancer Res 20: 861-867, 2000.
18. Hooijberg JH, Boxterman M, Heijn M, Fles DLA, Lankelma J and Pinedo HM: Modulation by isoflavonoids of the ATP-ase activity of the multidrug resistance protein. FEBS Lett 413: 344-348, 1997.
19. Versantvoort CH, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J and Broterman HJ: Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68: 939-946, 1993.
20. Sharom FJ: The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 160: 161-175, 1997.
21. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG and Cole S: Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 59: 1171-1180, 2001.
22. Michalak K, Hendrich AB, Wesolowska O and Pola A: Compounds that modulate multidrug resistance in cancer cells. Cell Biol Mol Lett 6: 362-368, 2001.
23. Castro AF and Altenberg GA: Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 53: 89-93, 1997.
24. Phang JM, Poore CM, Lopaczynska J and Yeh GC: Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53: 5977-5981, 1993.
25. Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H and Sawada Y: Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 395: 193-201, 2000.